Showing results (271-280 of 339) with videos related to

Sort By:
Pageof 34
European Journal of Pain (London, England)|July 12, 2023
Pain, mental health and healthcare utilization: Impact of the COVID-19 pandemic on youth with chronic pain, parents and siblingsSabine Soltani, Tieghan Killackey, Kathryn A Birnie, et al.
Allergy|May 27, 2020
Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacksMarc A Riedl, Marcus Maurer, Jonathan A Bernstein, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 4, 2013
Analysis of hereditary angioedema attacks requiring a second dose of ecallantideH Henry Li, Marilyn Campion, Timothy J Craig, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 20, 2023
Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING StudyMarcus Maurer, William R Lumry, H Henry Li, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|February 5, 2025
Artificial intelligence-based clinical decision support in the emergency department: A scoping reviewHashim Kareemi, Krishan Yadav, Courtney Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2025
Vamp3/syntaxin 4 mediates the basolateral membrane fusion of TfR transcytosis across the BBB and is exploited by pathogenic E. coliBin Liu, Yingying Su, Hao Sun, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 12, 2023
Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysisWilliam Lumry, Timothy Craig, John Anderson, et al.
BMC Pediatrics|August 1, 2015
Alberta Provincial Pediatric EnTeric Infection TEam (APPETITE): epidemiology, emerging organisms, and economicsStephen B Freedman, Bonita E Lee, Marie Louie, et al.
Pediatrics|December 13, 2016
Management of Children With Hereditary Angioedema Due to C1 Inhibitor DeficiencyMichael M Frank, Bruce Zuraw, Aleena Banerji, et al.
Advances in Therapy|May 2, 2026
Comparative Efficacy of Recombinant C1 Inhibitor Versus Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks: A Matching-Adjusted Indirect Treatment ComparisonJohn Anderson, Nihal Narsipur, Douglas Jones, et al.
Pageof 34